As of June 2023, (US) FDA has granted approval for a number of psychotropic drugs on market that might usher an innovative sparkle in psychopharmacotherapy. This is a recap to update busy clinicians.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ajp.2023.103684 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!